Molecules 2012, 17
13871
α-ketoacetal 3e (67.6 mg, 78%) as a pale yellow liquid. Rf = 0.40 n-hexane-EtOAc (4:1). νmax (film):
1
2931, 2216, 1683, 1455, 1260, 1187, 1118, 1074, 847 cm−1. H-NMR (500 MHz; CDCl3): δ 4.60
(s, 1H) H-1, 3.35 (s, 6H) (OCH3)2, 2.09 (s, 3H) H-5. 13C-NMR (125 MHz; CDCl3): δ 182.1 (C-2),
103.2 (C-1), 94.7 (C-3), 78.3 (C-4), 54.5 (OCH3), 4.5 (C-5). EI-HRMS: calculated for C7H10O3
142.0630; observed 142.0621.
1,1-Dimethoxy-4-phenylbut-3-yn-2-one (3f). Following the General Procedure described above, N-
methoxy-N-methylacetamide (2a, 100 mg, 0.61 mmol) was treated with PhCCMgBr (0.92 mmol),
affording α-ketoacetal 3f (103.3 mg, 83%) as a pale yellow solid. Rf = 0.40 n-hexane-EtOAc (4:1).
1
νmax (film): 2918, 2204, 1679, 1489, 1444, 1070, 758, 689 cm−1. H-NMR (500 MHz; CDCl3):
δ 7.27–7.43 (m, 5H) Ar, 4.76 (s, 1H) H-1, 3.50 (s, 6H) (OCH3)2. 13C-NMR (125 MHz; CDCl3): δ 182.3
(C-2), 133.4 (C-o), 131.1 (C-p), 128.6 (C-m), 119.6 (C-i), 103.00 (C-1), 94.9 (C-4), 86.4 (C-3), 54.4
(OCH3)2. EI-HRMS: calculated for [M-OMe]+· (C11H9O3) 173.0603; observed 173.0607.
1,1-Dimethoxy-2-(4-methylphenyl)-ethan-2-one (3g). Following the General Procedure described
above, N-methoxy-N-methylacetamide (2a, 100 mg, 0.61 mmol) was treated with 4-Me-C6H4MgBr
(0.92 mmol), affording α-ketoacetal 3g (94 mg, 79%) as a pale yellow liquid. Rf = 0.46
1
n-hexane-EtOAc (4:1). H-NMR (500 MHz; CDCl3): δ 8.12 (d, 2H, J = 8.1 Hz) H-o, 7.36 (d, 2H,
13
J = 8.1 Hz) H-m, 5.23 (s, 1H) H-1, 3.48 (s, 6H) (OCH3)2, 2.43 (s, 3H) CH3. C-NMR (125 MHz;
CDCl3): δ 193.0 (C-2), 144.6 (C-p), 131.3 (C-i), 129.6 (C-o), 129.2 (C-m), 103.1 (C-1), 54.4 (OCH3)2,
21.7 (CH3) [37–39].
1,1-Dimethoxy-2-(4-fluorophenyl)-ethan-2-one (3h). Following the General Procedure described
above, N-methoxy-N-methylacetamide (2a, 100 mg, 0.61 mmol) was treated with 4-F-C6H4MgCl
(0.92 mmol), affording α-ketoacetal 3h (112 mg, 92%) as a pale yellow liquid. Rf = 0.44
1
n-hexane-EtOAc (4:1). H-NMR (500 MHz; CDCl3): 8.17 (m, 2H) H-o, 7.13 (m, 2H) H-m, 5.12 (s,
1H) H-1, 3.48 (s, 6H) (OCH3)2. 13C-NMR (125 MHz; CDCl3): δ 191.9, (C-2), 167.0 (1J (C-F) = 254.3 Hz,
C-p), 132.4 (3J (C-F) = 9.3 Hz, C-o), 130.1 (4J (C-F) = 3 Hz, C-i), 115.5 (2J (C-F) = 21.6 Hz, C-p),
104.1 (C-1), 54.1 (OCH3)2 [37–39].
1,1-Dimethoxy-2-(3-methoxyphenyl)ethan-2-one (3i). Following the General Procedure described
above, N-methoxy-N-methylacetamide (2a, 100 mg, 0.61 mmol) was treated with 3-MeO-C6H4MgBr
(0.92 mmol), affording α-ketoacetal 3i (99 mg, 77%) as a pale yellow liquid. Rf = 0.37
1
n-hexane-EtOAc (4:1). H-NMR (500 MHz; CDCl3): δ 7.72 (dd, 1H, J = 8.0, 1.5 Hz) H-6', 7.61 (dd,
1H, J = 2.7, 1.5 Hz) H-2', 7.37 (t, 1H, J = 8.0 Hz) H-5', 7.13 (dd, 1H, J = 8.0, 2.7 Hz) H-4', 5.23 (s,
13
1H) H-1, 3.86 (s, 3H) ArOCH3, 3.47 (s, 6H) (OCH3)2. C-NMR (125 MHz; CDCl3): δ 193.2 (C-2),
159.6 (C-3'), 135.0 (C-1'), 129.4 (C-5'), 122.2 (C-6'), 120.3 (C-4’), 113.5 (C-2'), 103.0 (C-1), 55.3
(-C6H4-OCH3), 54.4 (OCH3)2 [40,41].
1,1-Dimethoxy-3-phenilpropan-2-one (3j). Following the General Procedure described above,
N-methoxy-N-methylacetamide (2a, 100 mg, 0.61 mmol) was treated with BnMgCl (0.92 mmol),
affording α-ketoacetal 3j (96 mg, 81%) as a pale yellow liquid. Rf = 0.44 n-hexane-EtOAc (4:1).
1H-NMR (500 MHz; CDCl3): δ 7.15–7.35 (m, 5H) Ar, 4.53 (s, 1H) H-1, 3.86 (s, 2H) H-3, 3.41 (s, 6H)